849 Optimization of a GM3-containing liposomal vaccine that delivers antigen to CD169+ splenic macro...
849 Optimization of a GM3-containing liposomal vaccine that delivers antigen to CD169+ splenic macrophages
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundAlthough promising developments in cancer vaccination have been made, therapeutic effectiveness is often insufficient. Liposomal vaccine effectiveness could be enhanced by antigen encapsulation and incorporation of molecules that actively target to antigen presenting cells to enhance T cell activation. CD169-expressing splenic macrophages...
Alternative Titles
Full title
849 Optimization of a GM3-containing liposomal vaccine that delivers antigen to CD169+ splenic macrophages
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b21fdaa09dd94dd0aa3e0e719bd81c27
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b21fdaa09dd94dd0aa3e0e719bd81c27
Other Identifiers
E-ISSN
2051-1426
DOI
10.1136/jitc-2020-SITC2020.0849
